Clinical Trial Update: QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating QL1706 with bevacizumab, with or without chemotherapy, in patients with non-squamous non-small cell lung cancer who pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• QL1706

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: NSCLC | Phase 2 | Status: NOT_YET_RECRUITING